ALS Global

ALS Global

Global testing solutions with data-driven insights

Overview

ALS Global provides testing services to clients across many industries worldwide. It uses state-of-the-art technologies and innovative methodologies to perform comprehensive tests, with international teams delivering high-quality services and personalized solutions backed by local expertise. The company helps clients turn data into actionable insights to improve safety and health outcomes. Compared with competitors, ALS Global combines a global footprint with local knowledge and tailored approaches, offering data-driven results rather than one-size-fits-all offerings. The goal is to enable a safer and healthier world by applying rigorous testing, analytics, and domain experience to client needs.

Significant Headcount Growth

About ALS Global

Simplify's Rating
Why ALS Global is rated
B
Rated B on Competitive Edge
Rated A on Growth Potential
Rated C on Differentiation

Industries

Data & Analytics

Industrial & Manufacturing

Healthcare

Company Size

10,001+

Company Stage

IPO

Headquarters

Brisbane, Australia

Founded

1863

Get referred to ALS Global

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • FY26 revenue rose 10.7%, with underlying NPAT up 25.8% to A$381.2 million.
  • Free cash flow hit A$674.1 million, cutting leverage to 1.5x after 2025 fundraising.
  • York accelerates Northeast PFAS demand, while Nuvisan savings target €25 million annual run-rate.

What critics are saying

  • Nuvisan restructuring runs through 2026, with €20 million costs and execution risk in Berlin.
  • A failed Nuvisan turnaround destroys European CRO economics and forces another impairment.
  • Any York, Wessling, or Nuvisan integration miss would compress margins and delay deleveraging.

What makes ALS Global unique

  • ALS Global spans commodities, environmental, and life sciences across 19,000 employees and 65 countries.
  • Its York, Wessling, and Nuvisan acquisitions deepen environmental testing and pharma CRO breadth.
  • FY26 revenue reached A$3.32 billion, reflecting scale competitors struggle to match.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Annual Leave

Car Parking on-site

Group Personal Pension Plan

Flexible Work Hours

Remote Work Options

Paid Vacation

Wellness Program

Mental Health Support

Phone/Internet Stipend

Home Office Stipend

Stock Options

Company Equity

401(k) Retirement Plan

401(k) Company Match

Conference Attendance Budget

Training Programs

Learning budget

Education allowance

Professional Development Budget

Family Planning Benefits

Fertility Treatment Support

Adoption Assistance

Childcare Support

Elder Care Support

Pet Insurance

Bereavement Leave

Sabbatical Leave

Relocation Assistance

Employee Referral Bonus

Performance Bonus

Profit Sharing

Employee Stock Purchase Plan

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

PTO

Paid Sick Leave

Paid Holidays

Hybrid Work Options

Remote Work Options

Unlimited Paid Time Off

Paid Vacation

Stock Price

Growth & Insights and Company News

Headcount

6 month growth

19%

1 year growth

19%

2 year growth

19%
Yahoo Finance
May 20th, 2026
ASX stocks undervalued by up to 30% amid market caution

Duratec, an Australian infrastructure services provider, is trading at A$2.46, approximately 30.4% below its estimated fair value of A$4.80 based on cash flows. The company delivers assessment, protection and refurbishment services for steel and concrete infrastructure across defence, energy, buildings and mining sectors. With a market capitalisation of A$619.58 million, Duratec generates revenue across four segments: Defence (A$166.12 million), Mining & Industrial (A$121.91 million), Buildings & Facades (A$121.01 million), and Energy (A$71.63 million). The analysis comes as the Australian market faces headwinds from rising US bond yields and price pressures, prompting investors to seek undervalued opportunities. A broader screening identified 40 ASX stocks potentially trading below their intrinsic values based on discounted cash flow analysis.

Business News Australia
May 27th, 2025
ALS raising $350m to expand 'at capacity' testing hubs globally and push revenue to $3.3b

Diversified testing service provider ALS Limited (ASX: ALQ) is raising $350 million to fund an expansion of its testing hubs globally over the next five years as the group edges closer to achieving revenue of $3.3 billion by FY27.

RC Biz Journal
Apr 24th, 2024
Nyack-based York Analytical Laboratories Bought By ALS Limited; Pearl River Farmers' Market Returns For A Full Season; CHPE Pre-Construction Open House

Nyack-based York Analytical Laboratories, Inc. has been acquired by ALS Limited to accelerate growth of its environmental testing services in the Northeast U.S.

TipRanks
Apr 3rd, 2024
State Street Corporation Acquires 5.13% of ALS Limited

State Street Corporation acquires 5.13% of ALS Limited.

Business News Australia
Mar 27th, 2024
ALS expands environmental testing arm via $225m acquisitions

Diversified testing service provider ALS (ASX: ALQ) is expanding its environmental services operations through two separate acquisitions in the US and Europe to

Recently Posted Jobs

Sign up to get curated job recommendations

ALS Global is Hiring for 210 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →